Wahlstrom Mats insider trades
Wahlstrom Mats has filed 18 Form 4s with the SEC that we hold, for Coherus Oncology, Inc. (CHRS) (Director) and TriSalus Life Sciences, Inc. (TLSI) (Director). Across all of them we count 4 purchases worth $221.6K and 1 sale worth $74.0K reported on Form 4. In the last 12 months: 1 purchase ($151.8K) and 0 sales ($0). The largest single trade was a purchase of 60,000 shares of TriSalus Life Sciences, Inc. worth $151.8K, dated 2026-05-15. The first filing on our record is dated 2022-02-11 and the latest 2026-06-09.
Coherus Oncology, Inc. (CHRS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-05-23 | S, sale reported on Form 4 | 99,988 | $74.0K | 2025-05-28 |
TriSalus Life Sciences, Inc. (TLSI)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-11-20 | P, purchase reported on Form 4 | 2,040 | $8.5K | 2024-11-22 |
| 2024-11-21 | P, purchase reported on Form 4 | 8,687 | $38.6K | 2024-11-22 |
| 2024-11-22 | P, purchase reported on Form 4 | 5,000 | $22.8K | 2024-11-25 |
| 2026-05-15 | P, purchase reported on Form 4 | 60,000 | $151.8K | 2026-05-18 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1459154) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms